Boobalan Pachaiyappan
Stock Analyst at Roth MKM
(0.1)
# 2532
Out of 5,230 analysts
10
Total ratings
37.50%
Success rate
-8.63%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CRVO CervoMed | Maintains: Strong Buy | 15 20 | 9.15 | 118.58% | 3 | Mar 18, 2025 | |
VRNA Verona Pharma | Initiates Coverage On: Buy | 68 | 65.14 | 4.39% | 1 | Jan 10, 2025 | |
RVPH Reviva Pharmaceutica... | Initiates Coverage On: Buy | 7 | 0.83 | 743.37% | 1 | Jan 10, 2025 | |
CING Cingulate | Initiates Coverage On: Buy | 12 | 4.38 | 173.97% | 1 | Jan 10, 2025 | |
GANX Gain Therapeutics | Maintains: Buy | 7 7 | 1.93 | 262.69% | 2 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 8.85 | 227.68% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.69 | 491.72% | 1 | Dec 5, 2024 |